ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758682 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758682; 2) Community: the network communities that were significantly associated with the response to NSC 758682; 3) Molecule: the relationships between components within communities and NSC 758682; 4) MDR: the compounds that were significantly associated with the NSC 758682.

NSC Compound Enrichment Correlation
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0459335986102865 0.38397052
NSC 763232 Null 0.0459335986102865 0.29805855
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0459335986102865 0.31862584
NSC 87500 Solacongestidine 0.0459335986102865 0.44335639
NSC 94945 Questiomycin A 0.0459335986102865 0.14690076
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0462077035966088 0.22906398
NSC 129518 Cyclopyrethrosin 0.0462077035966088 0.3663972
NSC 1390 Allopurinol 0.0462077035966088 0.14246133
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0462077035966088 0.49597246
NSC 222722 Null 0.0462077035966088 0.37246336
Total:153  Current:140    [First] [Prev] [Next] [Last]